Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Drug-Resistant Fungi Prompt a Five-Step Global Plan Ahead of WHO's 2026 Update
An international consortium of 50 researchers led by Radboudumc has issued a five‑step plan to curb the rise of drug‑resistant fungi. The strategy—covering awareness, surveillance, infection control, optimized drug use, and investment—aims to shape the World Health Organization’s 2026 Global Action Plan on antimicrobial resistance. Researchers warn that resistance is spreading from agricultural fungicide use to hospitals, endangering immunocompromised patients. With only five new antifungal classes introduced in the past 75 years, prevention is now critical.
Off the Shelf Cell Therapies for Bone Marrow Transplantation with Ossium Health’s Kevin Caldwell — Episode 251
In episode 251 of the Xtalks Life Science Podcast, Kevin Caldwell, CEO and co‑founder of Ossium Health, discusses the company’s pioneering off‑the‑shelf bone‑marrow therapy derived from deceased organ donors. The treatment aims to solve long‑standing clinical and logistical hurdles in...
Northamptonshire ICB Ranked England’s Most Digitally Mature
Northamptonshire Integrated Care Board has been ranked as England’s most digitally mature integrated care system, a dramatic rise from its low‑performing status just two years ago. The new Northamptonshire Care Record now aggregates health and social data for over 800,000...
Poll Reveals Millions of Americans Consult AI Before, After—And Sometimes Instead Of—Seeing a Doctor
A Gallup‑West Health poll of 5,660 U.S. adults finds that over 66 million Americans—one in four—have used AI tools or chatbots for health information in the past month. Most users (57%) turn to AI to supplement care, seeking quick answers or...
Viewpoint: CRISPR and mRNA — Under Attack by Technology Skeptics — Poised to Save Millions of Children with Rare Diseases
Rare genetic diseases affect roughly 25 million Americans and generate about $400 billion in annual medical costs, yet fewer than five percent have FDA‑approved therapies. The scarcity of treatments stems from the economics of drug development for tiny patient pools. Recent breakthroughs...
Idiopathic Hypersomnia and Narcolepsy: What’s the Difference?
Idiopathic hypersomnia (IH) and narcolepsy are distinct neurological sleep disorders that both cause excessive daytime sleepiness, but they differ in symptom patterns, underlying biology, and treatment options. IH is characterized by prolonged, unrefreshing sleep, severe sleep inertia, and cognitive fog...
Nearly 200 Radiology Reports Never Sent to Patients' Referring Providers, Health Authority Says
A regional health authority in New Zealand’s Northland region discovered that 180 radiology reports were never transmitted to referring providers, primarily due to an IT glitch affecting reports from June 2025 and earlier. Health NZ officials launched an investigation after patient complaints,...
Magnesium Effects in Critically Ill Patients
Magnesium deficiency is a pervasive problem in intensive care, affecting up to 65% of ICU patients even when serum tests appear normal. Low intracellular magnesium is linked to higher rates of sepsis, prolonged mechanical ventilation, and increased mortality. Clinical studies...
100+ Signatures in Six Hours for Cover All Coloradans
In 6 hours there are over 100 signatures supporting Cover All Coloradans I’m so grateful to you all for taking the time to show your support for this critical program 🫶🏾
Not About Food: The Brutal Truth About Malnutrition
Indonesia faces a chronic stunting crisis affecting millions of children, but the problem is less about food scarcity and more about a broken trust chain between mothers and the untrained community health workers, known as kader. Over 68 million mothers rely...
Re: Effect of a Clinical Decision Support System on Stroke Care Quality and Outcomes in Patients with Acute Ischaemic Stroke...
A cluster‑randomised trial (GOLDEN BRIDGE II) evaluated an AI‑driven clinical decision support system (CDSS) for acute ischemic stroke. The intervention lowered three‑month vascular events from 3.9% to 2.9% (adjusted HR 0.74) and improved several composite performance measures. However, the study found no significant...
Waist-to-Height Ratio Outperforms BMI in Predicting Hypertension Risk
A new study by the University of Eastern Finland and Rutgers University shows that waist‑to‑height ratio (WHtR) cut‑offs predict elevated blood pressure and hypertension more accurately than body mass index (BMI). Analyzing 19,124 U.S. participants from NHANES 2015‑2023, researchers found...
Study Identifies New Genes Linked to Severe Pregnancy Sickness
USC researchers expanded the genetic landscape of hyperemesis gravidarum, identifying nine additional genes alongside the previously known GDF15, GFRAL, IGFBP7, and PGR. The genome‑wide association study analyzed 10,974 HG cases and 461,461 controls across diverse ancestries, the largest cohort to...
FDA Requests Additional Safety Data on Eli Lilly's Newly Approved Obesity Pill Foundayo
The U.S. Food and Drug Administration has formally asked Eli Lilly to provide further safety information on its recently cleared oral GLP‑1 obesity medication Foundayo. The regulator’s letter, signed on April 1, flags liver‑injury signals and mandates post‑marketing studies on cardiovascular events,...
Eli Lilly’s Jaypirca Secures Fourth Phase III Win in CLL, Paving Way for Label Expansion
Eli Lilly announced that its BTK inhibitor pirtobrutinib (Jaypirca) achieved its fourth Phase III success in chronic lymphocytic leukemia, meeting the primary endpoint of improved progression‑free survival. The result clears a path for a U.S. label expansion and underpins a GlobalData...
FDA Launches READI-Home Innovation Challenge: Opportunities—And Tensions—For Home-Use Device Developers
On April 7, 2026 the FDA’s Center for Devices and Radiological Health launched the READI‑Home Innovation Challenge, a two‑phase program aimed at accelerating home‑use medical devices that can cut hospital readmissions. Developers submit a 16‑page Q‑Submission by September 30, after which up...
Labcorp, AWS and Datavant Launch AI‑Powered Platform to Speed Alzheimer’s Research
Labcorp announced a partnership with Amazon Web Services and Datavant to roll out an AI‑driven real‑world data platform for Alzheimer’s research. The platform promises to compress data‑preparation cycles from months to minutes, leveraging Labcorp’s diagnostic data and privacy‑preserving tokenization. The...
Behavioral Design Project Aims to Reduce Benzodiazepine Overuse
A collaborative project between the Universitat Oberta de Catalunya (UOC) and Badalona Serveis Assistencials (BSA) is launching a behavioural‑design pilot to curb long‑term benzodiazepine use in primary‑care. The three‑month intervention, beginning in April at the CAP Martí i Julià centre,...
Inflammation & Immune System - A Deep Dive Into Genetic Pathways for Actionable Insights
A detailed genetic analysis of inflammation and immune pathways identified three high‑impact homozygous variants: PTPN22 R620W, CFH Y402H, and NFE2L2 –617. The report translates these findings into concrete clinical actions, including autoimmune and thyroid screening, baseline retinal imaging for age‑related...
Eka Ventures Raises $107 Million for Second Impact Fund, Becomes UK’s Largest Early‑Stage ESG VC
Eka Ventures announced the final close of its second fund at $107 million (£80 million), taking total assets under management to $200 million. The fund will back up to 30 pre‑seed and seed‑stage UK startups in health, wellbeing and sustainability, underscoring growing investor...
HHS Ignores Proven Environmental Triggers for Autism
Here’s my statement from @BakerInstitute @RiceUniversity @RiceUNews on why this was always a nonstarter, meanwhile HHS refuses to investigate the few actual know environmental exposures that do interact with autism genes https://t.co/pxLaDLInlf
FDA Introduces Standardized Framework for Gene Therapy Safety
New FDA guidance on evaluating the safety of gene therapies will establish a more predictable development process as these measures are implemented They provide a standardized, layered framework for uncovering off-target effects and other safety issues https://t.co/D7lsBeZybT
MedPAC: No ‘Statistically Significant’ Impact From Medicare Advantage Growth On Home Health Margins
MedPAC reported that the growth of Medicare Advantage (MA) has not produced a statistically significant impact on home‑health provider margins, despite industry concerns. A 10% increase in MA penetration was linked to a modest 2.7% decline in all‑payer revenue for...
Exposing Antivaccine Rhetoric Masquerading as Real Science
1/n Here’s a thread on why this is nonsense. I think it’s important to debunk bc increasingly the antivaccine activists and their rhetoric are trying to sound more like real science even though it’s fake.
Study Finds Long COVID Leaves a Distinct Immune Signature in the Blood
A collaborative Australian‑Norwegian study identified a distinct set of inflammatory and neurological proteins in the blood of long COVID patients, measured six to nine months after infection. Machine‑learning analysis highlighted IL‑20, MCP‑1 and NBL1 as key discriminators from recovered and...
Experiences with Ezetimibe or Empagliflozin?
A Reddit longevity thread shows users taking ezetimibe (10 mg) and empagliflozin (10‑25 mg) report minimal side effects while noting modest metabolic benefits. Empagliflozin is praised for flattening post‑prandial glucose spikes but can increase urination; ezetimibe is credited with lowering LDL‑C to...
Whistleblower Sparks Investigation Into Health New Zealand’s Medical Scanning Services
A protected disclosure by consultant radiologist Dr. Bryan Wolf has triggered an independent inquiry into Health New Zealand’s radiology services, led by former Solicitor‑General Michael Heron KC. The board confirmed the investigation after earlier reports revealed patient harm from outdated...
MicroRNA Signature Predicts Localized Clear Cell RCC
A new commentary in the British Journal of Cancer re‑examines the Bio‑miR study, which proposed a microRNA signature to predict outcomes in localized clear cell renal cell carcinoma (ccRCC). The authors highlight statistical and reproducibility concerns, showing that several miRNA...
Egypt Launches State‑Faith Initiative to Deliver Free Household Mental‑Health Support
Egypt's Ministry of Youth and Sports announced a joint program with the Health Ministry, Al‑Azhar and the Orthodox Church to offer free, confidential psychological counseling to every Egyptian household. The initiative seeks to address soaring anxiety and depression rates by...
Common Osteoporosis Drugs Could Slow or Halt Aneurysm Progression
Researchers at Nagoya University discovered that clonal hematopoiesis, found in about 60% of aortic aneurysm patients, accelerates aneurysm expansion. In mouse models, Tet2‑mutant macrophages promoted elastin loss and matrix degradation via the RANK/RANKL pathway. Treatment with FDA‑approved osteoporosis drugs—anti‑RANKL antibodies...
A Bittersweet 20th Birthday for Romneycare
Mitt Romney marked the 20th anniversary of Massachusetts’ 2006 health‑care reform, known as Chapter 58 or “Romneycare,” highlighting its dramatic impact on coverage and its bipartisan origins. The law cut the state’s non‑elderly uninsured rate from 13.4% to 5.8% in the...
Turkish PDQoL-7 Validated for Older Adults
Turkish researchers have validated a version of the Parkinson’s Disease Quality of Life‑7 (PDQoL‑7) scale specifically for older adults, publishing the findings in BMC Geriatrics. The validation demonstrated strong reliability, internal consistency, and construct and criterion validity using factor analysis...
FDA Sends Letters to 2,200 Sponsors, Demanding Public Trial Results
The U.S. Food and Drug Administration has formally notified more than 2,200 drug developers that they must post pending clinical trial results on ClinicalTrials.gov, highlighting that nearly 30% of mandated studies remain unpublished. The agency warns of civil penalties and...
Botanic Healthcare Appoints Kamalakar V. Arcot as Group CEO to Drive Global Expansion
Botanic Healthcare announced the appointment of Kamalakar V. Arcot as Group Chief Executive Officer. The veteran executive brings more than 20 years of pharma and life‑science experience to steer the company’s global‑first strategy, strengthen supply‑chain execution and accelerate market expansion.
AWS Unveils Amazon Bio Discovery, Cutting Drug Design Time From Months to Weeks
Amazon Web Services launched Amazon Bio Discovery, an AI‑driven platform that lets researchers design and evaluate drug molecules without writing code. Early adopters such as Bayer, the Broad Institute and Memorial Sloan Kettering report that the tool can compress months‑long...
Aligning Exercise Timing with Body Clock Chronotype Could Reduce Cardiovascular Disease Risk
A randomized trial of 150 middle‑aged adults with cardiometabolic risk found that exercising in sync with one’s chronotype dramatically amplified health gains. Participants who timed brisk walking to their natural morning or evening preference saw systolic blood pressure drop 10.8 mm Hg,...
GLP-1 Goes For The Middle
Indian pharmaceutical firms are rapidly converting the GLP‑1 hype into scale after Novo Nordisk’s semaglutide patent expired in March. Generics from Sun Pharma, Torrent, Zydus and others have already captured more than 15% of the market, pushing Novo’s share down...
Patent‑Free COVID Vaccine Reaches 100 Million at $2‑3
Except the opposite, I make low cost vaccines that actually bypass big pharma, our patent-free COVID vaccine reached 100 million people at $2-3 per dose. It’s sad to see so many give up their critical thinking skills for conspiracy sites,...
Ohio Nursing Home Discharges Patient to Homeless Shelter, Triggering CMS Probe
The Eastland Rehabilitation and Nursing Center in Columbus placed a diabetic, fracture‑stricken resident at a city homeless shelter, prompting a Centers for Medicare & Medicaid Services (CMS) inspection. Regulators say the case reflects a growing pattern of nursing homes off‑loading...
Nvidia Drives Hyper‑realism While Research Shows VR’s Therapeutic Edge
Nvidia is accelerating ultra‑realistic rendering for PC games, but a Murdoch University study finds the same visual fidelity could boost positive emotional states in virtual reality. The findings suggest hardware advances may benefit education, health care and therapy as much...
Newfoundland Revises Approach to EHR Deployment
Newfoundland and Labrador Health Services (NLHS) has softened its rollout of the Epic‑based CorCare electronic health record, making participation optional for physicians and easing liability clauses tied to cyber‑breaches. The province will still launch the system province‑wide on April 25,...
EMF‑Controlled Gene Switch Reverses Aging In Vivo
EMF-inducible gene switch gene switch enables in vivo rejuvenation by reversing aging phenotypes Electromagnetic field-inducible in vivo gene switch for remote spatiotemporal control of gene expression https://t.co/yeIDzXChWV
Expect Glitches with New, Quebec EHR, Chief Says
Quebec's health authority Santé Québec will launch the province‑wide Digital Health Record (DSN) on May 9, using Epic Systems as the primary vendor. CEO Geneviève Biron warned that minor technical glitches and a surge in support tickets are normal during the first...
Humber River Health Receives $50 Million Gift
Humber River Health announced a $50 million (≈ $37 million USD) donation from Jay and Barbara Hennick, prompting the Wilson site to be renamed Hennick Humber Hospital. The gift, one of Canada’s largest to a community hospital, will fund advanced technologies, research, education and...
Alberta Aims for Diagnostic Tests without Referral
Alberta Health Minister Adriana LaGrange introduced legislation that would let residents pay to bypass a doctor referral for diagnostic tests such as CT scans, MRIs and blood work. The bill is framed as a capacity‑building measure that complements, not replaces,...
NTU Singapore, SUSTech, and Lipigon Advance Inhaled Nanocarrier Therapy for Severe Lung Infections
Nanyang Technological University in Singapore, Southern University of Science and Technology in China, and Sweden’s Lipigon Pharmaceuticals have pushed their inhaled nanocarrier drug targeting ANGPTL4 into non‑human primate testing. The move clears the path toward an IND filing and could...
'I'm Not Being Listened To' - New Health Plan Launched as Women Say They Are Still Ignored
Britain’s Labour government has unveiled an updated women’s health strategy amid growing criticism that the NHS is ignoring female patients. Waiting lists for gynecological procedures have doubled to over 565,000 since 2020, and the plan introduces a “patient power payment”...
Helical Secures $10 Million Seed Round to Launch Virtual AI Lab for Pharma
Helical Ltd., a biotech AI startup, closed a $10 million seed round led by Redalpine Venture Partners, with participation from Gradient, BoxGroup, Frst Capital and several AI CEOs. The funding will accelerate deployment of its virtual AI lab that turns foundation...
$1 Million Gift Advances Healthy Aging Research at OTU
Ontario Tech University has received a $1 million CAD (≈$740,000 USD) donation from the Sienna for Seniors Foundation to launch the Sienna Senior Living Research Centre for Healthy Aging and Happiness. The centre will pursue applied, human‑centred research across three pillars: enhancing...
Novari Referral System to Be Used Across Ontario
Novari Health, a VitalHub subsidiary, has secured a multi‑year agreement with Ontario to roll out its cloud‑based central intake and referral management platform across the province. The deployment is part of Ontario’s Patients Before Paperwork initiative, which aims to streamline...